Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety of genetic diseases. However, one major roadblock to delivering gene ...

In the complex process of producing a gene therapy, bioprocessors depend on assays to monitor the attributes of the product at various stages. Scientists at Thermo Fisher Scientific focus on ...

Skylark Bio ("Skylark"), a clinical-stage biotechnology company developing targeted genetic medicines for hearing loss, and ...

The MarketWatch News Department was not involved in the creation of this content. BioCurie to Receive Up to $9.3 Million ARPA-H Award to Build AI Platform for Scalable Gene Therapy Manufacturing Key ...

Proprietary process reduces development timelines from 18 months to as little as 3, eliminates reliance on traditional plastic flatware, and offers rapid, globalization — validated in AAV production.

Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...

Strategic collaboration creates a seamless US-APAC manufacturing corridor, enabling local production for global clinical trials and enhancing patient access to next-generation medicines. COLUMBUS, ...

Developed in collaboration with Korea's top clinical and hospital network, the integrated platform combines globally ...

WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies ...

While Landmark will now be flying Artis' banner, Artis said in an April 2 press release that Landmark will continue to operate as a distinct entity. (iStock / Getty Images Plus) Out of the shadows, ...